Stay updated on Talimogene & Pembrolizumab Combo in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Talimogene & Pembrolizumab Combo in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Talimogene & Pembrolizumab Combo in Melanoma Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    A notice has been added explaining NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” and linking to transition updates and FAQs.
    Difference
    0.5%
    Check dated 2026-10-24T17:13:14.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2, while the study record content remains unchanged.
    Difference
    0.1%
    Check dated 2026-10-17T17:04:56.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The site footer’s displayed revision changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-10T18:00:31.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    Revision: v3.7.0 replaces the previous Revision: v3.6.6, indicating a new version of the study record has been published.
    Difference
    0.1%
    Check dated 2026-09-19T19:13:45.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    A new revision entry v3.6.6 was added to the study record history. The previous entry v3.6.5 was removed, updating the revision log to reflect the latest version.
    Difference
    0.1%
    Check dated 2026-08-29T19:13:34.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    A new revision entry v3.6.5 was added to the study history. The previous revision v3.6.4 was removed from the list.
    Difference
    0.1%
    Check dated 2026-08-08T18:18:28.000Z thumbnail image

Stay in the know with updates to Talimogene & Pembrolizumab Combo in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Talimogene & Pembrolizumab Combo in Melanoma Clinical Trial page.